EXPERIENCE*
2019 - Present, Istanbul/Istanbul/Turkey
MEMORIAL ATAŞEHİR HOSPITAL
General Surgeon
2012 - 2019, Diyarbakır/Diyarbakır/Turkey
DİCLE UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2011 - 2012, Van/Van/Turkey
VAN REGIONAL TRAINING AND RESEARCH HOSPITAL
General Surgeon
2009 - 2011, Van/Van/Turkey
HAKKARİ STATE HOSPITAL
General Surgeon
2004 - 2009, Van/Van/Turkey
YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE
General Surgeon
2002 - 2004, Van/Van/Turkey
HACIBEKİR HEALTH CENTER
General Practitioner
*EDUCATION*
2018 - 2019, Diyarbakır/Turkey
Associate Professor
2015, Ohio/USA
OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
Neck Dissection Training
2012 - 2018, Diyarbakır/Turkey
Assistant Professor
1996 - 2002, Adana/Turkey
ÇUKUROVA UNIVERSITY
FACULTY OF MEDICINE - Medical Doctor Education
Mehr lesenArztbesuch | preis auf anfrage |
Radiojodtherapie | $2500 - $4500 |
Thyreoidektomie | $5000 - $6900 |
Arztbesuch | preis auf anfrage |
Thyreoidektomie | $9100 - $12750 |
Arztbesuch | preis auf anfrage |
Thyreoidektomie | $5000 - $15000 |
2014 : The world's first robotic oral thyroidectomy developed by Kim Hoon-yub
2011 ~ : Fellow of the International Society of Neuro Monitoring Research
2008 ~ : Permanent member of Korean Society of Endoscopic & Laparoscopic Surgeons
2008 ~ : Permanent member of Korean Society of Surgical Oncology
2008 ~ : Permanent member of the Asia Oceania Thyroid Association
2014 ~ : Research Professor, the Korean Society of Endoscopic & Laparoscopic Surgeons
2014 ~ : Member of planning Committee at the Korean Association of Thyroid and Endocrine Surgeons, member of the Medical Rights Advisory Committee
2012 ~ : Member of the International Surgery Research Forum
2015 ~ : Member of the American Thyroid Association
2015 ~ 2016: Research Professor, Division of Head and Neck Surgery, Johns Hopkins University School of Medicine, USA
Mehr lesen
Arztbesuch | preis auf anfrage |
Thyreoidektomie | $7734 - $9139 |
NUTRITION AND DIET SPECIALIST
Ezgi Sevic graduated from Hacettepe University, Department of Nutrition and Dietetic as Honor Student. During her education, she conducted studies on “'The Effect of Hedonic Eating Behavior on Obesity', 'Total Parenteral Nutrition in Children' and 'The Relationship Between Insulin Resistance and Obesity'.” During her education, she took part in the field in studies on determining the nutritional status of the society. She worked as intern dietitian in Hospitals of Hacettepe University (Oncology Hospital, Adults Hospital, İhsan Doğramacı Child Hospital), Dışkapı Yıldırım Beyazıt Training and Research Hospital and many Community Health Centres.
She worked in Izmir Private Ekol Hospital. She successfully completed the 'Bariatric Nutrition Course' and the 'Innovations in Obesity Course'. She has participated in many training and seminar programs in her field.
Interests: Post- Metabolic and Bariatric Surgery Nutrition, the Nutrition in Chronicle Diseases, Nutrition in Individuals with Diabetes, Nutrition in Cancer, Nutrition in Congenital Metabolic Diseases, Food Intolerances, Body Weight Control, Child and Adolescent Nutrition, Nutrition in Old Age, Nutrition in Pregnancy and Lactation.
Dietit. Ezgi Sevic knows advanced English.
Mehr lesenProf. Andrea Lania has graduated at the Università degli Studi of Milan and is specialized in endocrinology. He is the Unit Director of Endocrinology and Diabetology in Humanitas Research Hospital and his specialization is pituitary diseases, pituitary adenomas, thyroid cancer, pancreatic neuroendocrine tumors, poorly differentiated neuroendocrine carcinomas.
Medical areas of interest:
Pituitary tumors, hypopituitarism, acromegaly, Cushing’s disease and syndrome, neuroendocrine tumors, thyroid and thyroid diseases, adrenal and adrenal diseases, hypogonadism.
Research areas of interest:
Study of the pathogenetic mechanisms of pituitary and neuroendocrine tumors, of the molecular mechanisms responsible for the different response of pituitary and neuroendocrine tumors to medical therapy.
Prof. Lania published 198 peer-reviewed papers (Google Scholar H-Index 47; Scopus H-Index 38, cit tot 4604)
Prof. Lania has a long standing expertise in the field of intra-cellular signaling in endocrine tumors. In particular, in the past ten years, he contributed to analyze the role of PKA regulatory subunits in the pathogenesis and control of cell proliferation of endocrine tumors. Moreover, he contributed to define the role of SSTR5 domains involved in the intracellular trafficking of this receptor in human pituitary cells and to analyze the impact of DR2R and SSTR2&5 polymorphic variants on both the clinical outcome and response to medical treatment in patients with pituitary tumors.
Recently, he contributed to identify the role of cytoskeleton protein FLNA in mediating both intracellular signaling and membrane targeting of somatostatin type 2 receptor and D2R in pituitary and pancreatic neuroendocrine tumors. Finally, he contributed to explore the intracellular mechanisms possibly involved in mediating the interplay between drugs commonly used in the treatment of neuroendocrine tumors.
Previous experience:
2005-2008 Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy
Director of Endocrinologic Day Hospital and surgery on pituitary disorders.
Publications: https://www.ncbi.nlm.nih.gov/pubmed?term=lania%20A
Mehr lesenEducation and Experience
Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Mehr lesenMedical Interests
Diabetes
Thyroid Diseases
Obesity
Hyperlipidemia
Secondary Hypertension (Resistant Hypertension)
Pituitary Gland Diseases
Adrenal Gland Diseases
Hirsutism (Increased Hairiness)
Irregular period
Delayed Puberty (Delayed Puberty)
Metabolic Bone Diseases
Osteoporosis
Menopause
Gynecomastia
Excessive Sweating (Hyperhidrosis)
Developmental Retardation
Education
Ziya Gokalp High School / 1993 - 1996
Gazi University Faculty of Medicine / 1997 - 2004
Ankara Numune Training and Research Hospital / 2005-2009 / (Internal Medicine Clinic)
Ankara Numune Training and Research Hospital / 2010-2013 / (Endocrinology and Metabolic Diseases Clinic)
Experience
Ankara Numune Training and Research Hospital / Clinic of Internal Medicine / Assistant / 2005 -2010
Bala District State Hospital / Specialist / State Service Obligation / 2010 -2010
Ankara Numune Training and Research Hospital / Clinic of Endocrinology and Metabolism Diseases / Minor Assistant / 2010- 2013
Ankara Numune Training and Research Hospital / Clinic of Endocrinology and Metabolism Diseases / Specialist / 2013 - 2014
Kocaeli Darıca Farabi State Hospital / Clinic of Endocrinology and Metabolism Diseases / Specialist / 55th Term State Service Obligation / 2014 - 2015
Health Sciences University Derince Training and Research Hospital / Clinic of Endocrinology and Metabolism Diseases / Specialist / 2015- 2016
Health Sciences University Derince Training and Research Hospital / Clinic of Endocrinology and Metabolism Diseases / Associate Professor / 2016-2017
Health Sciences University Derince Training and Research Hospital / Clinic of Endocrinology and Metabolism Diseases / Associate Professor
Diyarbakır Private Practice / Associate Professor / 2020-2022
Liv Hospital Vadistanbul 2022-
Memberships
Turkish Endocrine and Metabolism Society
European Society of Endocrinology
Mehr lesen